Anebulo Pharmaceuticals, Inc.
ANEB
$2.37
$0.041.72%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/4/2025
-
MarketBeat
11/15/2025
-
Ticker Report
11/13/2025
-
GuruFocus
11/13/2025
-
The Fly
11/13/2025
-
Business Wire
10/25/2025
-
MarketBeat
10/8/2025
-
MarketBeat
9/29/2025
-
Nasdaq News: Markets
9/29/2025
-
Zolmax
9/29/2025
-
GuruFocus
9/29/2025
-
MarketBeat
9/29/2025
-
Business Wire
9/25/2025
-
GuruFocus
9/25/2025
-
GuruFocus
9/25/2025
-
TipRanks Financial Blog
9/25/2025
-
The Fly
9/25/2025
-
Business Wire
9/17/2025
-
MarketBeat
9/12/2025
-
GuruFocus
9/12/2025
-
GuruFocus
9/12/2025
-
TipRanks Financial Blog
9/12/2025
-
The Fly
9/12/2025
-
Business Wire
9/9/2025
-
Simply Wall St
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
512 598 0931
Address
1017 Ranch Road 620 South
Lakeway, TX 78734
Lakeway, TX 78734
Country
Year Founded
Business Description
Sector
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute...
more